Archive · 18 Jun 2025
SMT Plans ₹2,000 Crore IPO for Cardiac Stent Business
Imagine a company called SMT that makes important medical devices called stents.
They help people with heart problems.
SMT wants to sell some of its company's shares to the public to raise money.
This is called an IPO.
This time, existing investors will sell their shares.
SMT tried to do this before in 2021 but didn't go through with it.
Since then, the company has made more money and is doing better.
The market for these medical devices is growing, so the company is hoping to do well.
SMT, a cardiac stent manufacturer, plans a ₹1,500-2,000 crore IPO.
The IPO will be an offer-for-sale, with existing investors selling shares.
The company's first IPO attempt was in 2021; they raised ₹170 crore in 2023.
SMT recorded ₹909 crore revenue in FY24, up from ₹588 crore in FY21.
The Indian cardiovascular device market is expected to grow at 14-15% CAGR.
- Who
- Sahajanand Medical Technologies (SMT).
- What
- SMT, a cardiac stent manufacturer, is planning an IPO.
- When
- Draft papers are expected to be filed in July, with a potential listing by the end of the year.
- Where
- India
- Why
- To allow existing investors to offload their stakes.
Concerns
Market Outlook
Financial Health
Concerns
Concerns around large working capital needs, R&D-linked volatility in margins, and regulatory exposure.
Market Outlook
No opposing viewpoints identified.
- Company
- Sahajanand Medical Technologies (SMT)
- IPO Size
- ₹1,500-2,000 crore
- IPO Type
- Offer-for-sale
- FY24 Revenue
- ₹909 crore
- Market Share (DES segment)
- 25-30%
- Market Growth (CAGR)
- 14-15% over next decade